Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tissue Renewal without Stem Cells

Tissue Renewal without Stem Cells

After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...

Type I Diabetes II: Pathophysiology

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

Type I Diabetes I: Introduction

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...

Insulin Secretory Vesicles

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Response to letter re: "Artificial intelligence-powered real-time multimodal model for predicting recurrence and survival in head and neck cancer: a multicenter, multinational study".

ESMO open·2026

Same author

Artificial intelligence-powered real-time multimodal model for predicting recurrence and survival in head and neck cancer: a multicenter, multinational study.

ESMO open·2026

Same author

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with oncogene-addicted metastatic non-small-cell lung cancer.

ESMO open·2024

Same author

Reply to the Letter to the Editor regarding 'PFS, OS or toxicity: what is the most important factor in the treatment of EGFR-mutated lung cancer?' by T. Nishimura and H. Fujimoto.

Annals of oncology : official journal of the European Society for Medical Oncology·2024

Same author

Expression of PD-L1, PD-L2, and inflammatory gene expression profile in locally advanced head and neck squamous cell carcinoma.

ESMO open·2024

Same author

Nationwide precision oncology pilot study: KOrean Precision Medicine Networking Group Study of MOlecular profiling-guided therapy based on genomic alterations in advanced solid tumors (KOSMOS) KCSG AL-20-05.

ESMO open·2024

Search research articles

Related Experiment Video

Updated: Jun 19, 2026

Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System

Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System

Published on: December 16, 2021

Adult human beta-cell neogenesis?

C Demeterco¹, E Hao, S-H Lee

¹Department of Pediatrics, University of California San Diego, Rady Children's Hospital, La Jolla, USA.

Diabetes, Obesity & Metabolism

|October 13, 2009

Summary

Scientists are exploring ways to regenerate pancreatic beta-cells to reverse diabetes. Adult pancreas cells show plasticity, with stem cells in the exocrine part differentiating into beta-cells, offering new therapeutic avenues.

More Related Videos

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform

Published on: July 16, 2016

A Quantitative Assay for Insulin-expressing Colony-forming Progenitors

A Quantitative Assay for Insulin-expressing Colony-forming Progenitors

Published on: November 28, 2011

Related Experiment Videos

Last Updated: Jun 19, 2026

Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System

Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System

Published on: December 16, 2021

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform

Published on: July 16, 2016

A Quantitative Assay for Insulin-expressing Colony-forming Progenitors

A Quantitative Assay for Insulin-expressing Colony-forming Progenitors

Published on: November 28, 2011

Area of Science:

Endocrinology and Regenerative Medicine
Molecular and Cellular Biology

Background:

Diabetes mellitus (type 1 and type 2) is a major health concern.
Current therapeutic strategies aim to manage blood glucose levels.
Inducing endogenous beta-cell regeneration presents a promising approach to reverse diabetes.

Purpose of the Study:

To investigate the plasticity of adult pancreatic cells for beta-cell regeneration.
To explore the potential of stem/progenitor cells in the adult human pancreas.
To understand the mechanisms driving beta-cell neogenesis and replication.

Main Methods:

Review of existing evidence on beta-cell replication and neogenesis.
Identification and characterization of facultative stem cells in the adult human pancreas.
Analysis of factors influencing beta-cell mass expansion.

Main Results:

Adult pancreatic cells exhibit greater plasticity than previously thought.
A facultative stem cell population resides in the exocrine compartment of the adult human pancreas.
This stem cell population can differentiate into beta-cells under specific conditions.

Conclusions:

Beta-cell regeneration can be achieved through beta-cell replication or neogenesis.
The adult human pancreas harbors stem cells capable of beta-cell neogenesis.
Understanding stem cell mobilization is key for developing therapies for diabetes-induced beta-cell loss.